Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Contribution of IPSS-R Cytogenetics to Predict Outcome after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Jordan Gauthier, MD, Damaj Gandhi, MD PhD, Carole Langlois, MD, Marie Robin, MD PhD, Patrice Chevallier, MD PhD, Yves Beguin, MD PhD, Stephanie Nguyen, MD PhD, Pierre Bories, MD, Didier Blaise, MD PhD, Jerome Cornillon, Aline Clavert, Mohamad Mohty, MD PhD, Anne Huynh, MD, Anne Thiebaut, MD, Stephane Vigouroux, MD, Alain Duhamel, MDPhD, Ibrahim Yakoub-Agha, MD PhD

Blood (2014) 124 (21): 5609.

https://doi.org/10.1182/blood.V124.21.5609.5609

Published: 2014

Journal Articles

Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients

Nathalie Dhedin, MD, Jacques-Olivier Bay, MD, PhD, Patricia Ribaud, Mathieu Coudert, Marie T Rubio, MD, PhD, Philippe Agape, MD, Anne Thiebaut, MD, Alice Garnier, MD, Aurelie Faugeras, Nicole Lecorre, Madalina Uzunov, Nabila Kerbi-Hamimed, Gérard Socié, Noel Milpied, MD, Brigitte Autran, Anne Krivine, MD, PHD

Blood (2010) 116 (21): 1269.

https://doi.org/10.1182/blood.V116.21.1269.1269

Published: 2010

Journal Articles

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Nicole Raus, Daniela Revesz, MD, Jacques Troncy, MD, Youcef Chelgoum, MD, Jean-Paul Bourgeot, Philippe Dubost, Olivier Hequet, MD PhD, Franck E. Nicolini, MD PhD

Blood (2007) 110 (11): 3048.

https://doi.org/10.1182/blood.V110.11.3048.3048

Published: 2007

Journal Articles

Multi-Center Prospective Trial on Conditioning with Treosulfan, Fludarabine and ATG Before Allogeneic HSCT from Unrelated Donors.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD PhD, Nicole Raus, Reza Tabrizi, MD, Krimo Bouabdallah, MD, Didier Blaise, MD PhD, Mohamad Mohty, MD, Catherine Faucher, MD, Sabine Furst, MD, Jacques-Olivier Bay, MD PhD, Eric Hermet, MD, Noel Milpied, MD PhD

Blood (2007) 110 (11): 4949.

https://doi.org/10.1182/blood.V110.11.4949.4949

Published: 2007

Journal Articles

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Claudiu Plesa, MD, Quoc-Hung Le, MD, Youcef Chelghoum, MD, Mohamed Elhamri, PhD, Isabelle Tigaud, MD, Bruno Anglaret, MD, Sophie Ducastelle, MD, Marie-Claire Perrin, MD, Frank Nicolini, MD, Amine Belhabri, MD, Jacques Troncy, MD, Anne Thiebaut, MD, Daniela Revesz, MD, Eric Wattel, MD, Charles Dumontet, MD, Mauricette Michallet, MD, Xavier Thomas, MD

Blood (2007) 110 (11): 4352.

https://doi.org/10.1182/blood.V110.11.4352.4352

Published: 2007

Journal Articles

Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu Trial.

Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Anne Thiebaut, MD, Mohamed Elhamri, PhD, Emmanuelle Tavernier, MD, Nabaz Jaff, MD, Quoc-Hung Le, MD, Mauricette Michallet, MD,PhD

Blood (2006) 108 (11): 4558.

https://doi.org/10.1182/blood.V108.11.4558.4558

Published: 2006

Journal Articles

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Sophie Ducastelle, MD, Daniela Revesz, MD, Jacques Troncy, MD, Samira Mahmoudi, MD, Xavier Thomas, MD, PhD, Anne Thiebaut, MD, Franck E. Nicolini, MD, PhD, Emmanuelle Tavernier, MD, Quoc-Hung Le, MD, Youssef Chelgoum, MD, Aline Praire, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 5399.

https://doi.org/10.1182/blood.V106.11.5399.5399

Published: 2005

Journal Articles

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Mauricette Michallet, MD PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emmanuelle Tavernier, MD, Jacques Troncy, MD, Xavier Thomas, MD PhD, Youcef Chelghoum, MD, Aline Praire, Elodie Gadolet, Franck E. Nicolini, MD PhD, Gilles Clapisson, Irene Philip, MD

Blood (2004) 104 (11): 5221.

https://doi.org/10.1182/blood.V104.11.5221.5221

Published: 2004

Journal Articles

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emannuelle Tavernier, MD, Hanadi Rafii, MD, Daniela Revesz, MD, Jacques Troncy, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD, Olivier Hequet, MD, PhD, Jean-Paul Bourgeot, Franck E. Nicolini, MD, PhD

Blood (2004) 104 (11): 2305.

https://doi.org/10.1182/blood.V104.11.2305.2305

Published: 2004

Journal Articles

B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.

Emmanuelle Tavernier, MD, Anne Thiebaut, MD, Franck Nicolini, MD, PhD, Quoc Hung Le, MD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Daniela Revesz, MD, Olivier Hecquet, MD, PhD, Philippe Dubost, Jean-Paul Bourgeot, Mauricette Michallet, MD, PhD

Blood (2004) 104 (11): 5151.

https://doi.org/10.1182/blood.V104.11.5151.5151

Published: 2004

Journal Articles

Kinetics of Chimerism Conversion to Total Donor Profile: Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Franck E. Nicolini, MD PhD, Anne Thiebaut, MD, Emmanuelle Tavernier, MD, Hanadi Rafii, MD, Samira Mahmoudi, MD, Daniela Revesz, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD

Blood (2004) 104 (11): 1821.

https://doi.org/10.1182/blood.V104.11.1821.1821

Published: 2004

NARROW

Contribution of IPSS-R Cytogenetics to Predict Outcome after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Multi-Center Prospective Trial on Conditioning with Treosulfan, Fludarabine and ATG Before Allogeneic HSCT from Unrelated Donors.

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu Trial.

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.

Kinetics of Chimerism Conversion to Total Donor Profile: Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only